retatrutide vs semaglutide vs tirzepatide – Comparison & Benefits Retatrutide vs Semaglutide & Tirzepatide:

However, the patent term on the main compound has been extended by over five years as a result of a Patent Term Adjustment (PTA) and a Patent Term Extension (PTE)

Effects of Exogenous Glucagon-Like Peptide-1 on Gastric Emptying and Glucose Absorption in the Critically Ill: Relationship to Glycemia

However, Orforglipron's core patent (US20190225604A1) also discloses the possibility of replacing the carbon atom on the indole ring with a nitrogen atom

[DOI] [PubMed] [Google Scholar] 145.Singh-Franco D, et al

Dont escalate your dose too quickly

Clinical studies have shown impressive results: Semaglutide Average weight loss: 1215% of body weight Tirzepatide Average weight loss: 1822% of body weight Many patients lose 1025 kg over 1218 months when combined with healthy eating and physical activity